|
Posted: 28 Jan 2015 12:22 PM PST
By establishing protein design algorithms that simultaneously optimize drug candidates for both decreased immunogenic epitope content and high level stability and activity, researchers have established a novel testing platform. The work guides biotechnologists toward protein designs that function appropriately using sophisticated design algorithms.
 |
2015년 2월 2일 월요일
ScienceDaily: Computers & Math News
피드 구독하기:
댓글 (Atom)
댓글 없음:
댓글 쓰기